Author: BusinessWire

Company to Proceed with Phase 2 Development Program for Islatravir Subdermal Implant
KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a Phase 1 study evalu…

Company to Proceed with Phase 2 Development Program for Islatravir Subdermal Implant
KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a Phase 1 study evalu…

Topline clinical trial results showed LEUKINE® was safe, well tolerated and generated T cells targeted at the SARS-CoV-2 virus in patients hospitalized with COVID-19

LEUKINE® is currently being assessed in a clinical trial in US in COVID-19 patients
…

Topline clinical trial results showed LEUKINE® was safe, well tolerated and generated T cells targeted at the SARS-CoV-2 virus in patients hospitalized with COVID-19

LEUKINE® is currently being assessed in a clinical trial in US in COVID-19 patients
…

Safety Monitoring Committee review of second dose-level cohort allows advancement of Phase 1 RAD-18-001 study to third cohort dose level cohort
OSLO, Norway–(BUSINESS WIRE)–Oncoinvent AS, a clinical stage company advancing a pipeline of radiopharmac…

Safety Monitoring Committee review of second dose-level cohort allows advancement of Phase 1 RAD-18-001 study to third cohort dose level cohort
OSLO, Norway–(BUSINESS WIRE)–Oncoinvent AS, a clinical stage company advancing a pipeline of radiopharmac…

PITTSBURGH–(BUSINESS WIRE)–Noveome Biotherapeutics, Inc., a clinical stage biopharmaceutical company focused on developing next-generation biologics for the restoration of cellular integrity of damaged tissues, has appointed Christopher J. P. Velis t…

PITTSBURGH–(BUSINESS WIRE)–Noveome Biotherapeutics, Inc., a clinical stage biopharmaceutical company focused on developing next-generation biologics for the restoration of cellular integrity of damaged tissues, has appointed Christopher J. P. Velis t…

Veristat Supported the NDA and Celebrates This Milestone Achievement for Children and Their Families Fighting This Rare Disease
SOUTHBOROUGH, Mass.–(BUSINESS WIRE)–#rarediseaseday–Veristat, a scientific-minded, global clinical research organization…

Veristat Supported the NDA and Celebrates This Milestone Achievement for Children and Their Families Fighting This Rare Disease
SOUTHBOROUGH, Mass.–(BUSINESS WIRE)–#rarediseaseday–Veristat, a scientific-minded, global clinical research organization…